A Viral microRNA Cluster Strongly Potentiates the Transforming Properties of a Human Herpesvirus
Epstein-Barr virus (EBV), an oncogenic human herpesvirus, induces cell proliferation after infection of resting B lymphocytes, its reservoir in vivo. The viral latent proteins are necessary for permanent B cell growth, but it is unknown whether they are sufficient. EBV was recently found to encode microRNAs (miRNAs) that are expressed in infected B cells and in some EBV-associated lymphomas. EBV miRNAs are grouped into two clusters located either adjacent to the BHRF1 gene or in introns contained within the viral BART transcripts. To understand the role of the BHRF1 miRNA cluster, we have constructed a virus mutant that lacks all its three members (Δ123) and a revertant virus. Here we show that the B cell transforming capacity of the Δ123 EBV mutant is reduced by more than 20-fold, relative to wild type or revertant viruses. B cells exposed to the knock-out virus displayed slower growth, and exhibited a two-fold reduction in the percentage of cells entering the cell cycle S phase. Furthermore, they displayed higher latent gene expression levels and latent protein production than their wild type counterparts. Therefore, the BHRF1 miRNAs accelerate B cell expansion at lower latent gene expression levels. Thus, this miRNA cluster simultaneously enhances expansion of the virus reservoir and reduces the viral antigenic load, two features that have the potential to facilitate persistence of the virus in the infected host. Thus, the EBV BHRF1 miRNAs may represent new therapeutic targets for the treatment of some EBV-associated lymphomas.
Vyšlo v časopise:
A Viral microRNA Cluster Strongly Potentiates the Transforming Properties of a Human Herpesvirus. PLoS Pathog 7(2): e32767. doi:10.1371/journal.ppat.1001294
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001294
Souhrn
Epstein-Barr virus (EBV), an oncogenic human herpesvirus, induces cell proliferation after infection of resting B lymphocytes, its reservoir in vivo. The viral latent proteins are necessary for permanent B cell growth, but it is unknown whether they are sufficient. EBV was recently found to encode microRNAs (miRNAs) that are expressed in infected B cells and in some EBV-associated lymphomas. EBV miRNAs are grouped into two clusters located either adjacent to the BHRF1 gene or in introns contained within the viral BART transcripts. To understand the role of the BHRF1 miRNA cluster, we have constructed a virus mutant that lacks all its three members (Δ123) and a revertant virus. Here we show that the B cell transforming capacity of the Δ123 EBV mutant is reduced by more than 20-fold, relative to wild type or revertant viruses. B cells exposed to the knock-out virus displayed slower growth, and exhibited a two-fold reduction in the percentage of cells entering the cell cycle S phase. Furthermore, they displayed higher latent gene expression levels and latent protein production than their wild type counterparts. Therefore, the BHRF1 miRNAs accelerate B cell expansion at lower latent gene expression levels. Thus, this miRNA cluster simultaneously enhances expansion of the virus reservoir and reduces the viral antigenic load, two features that have the potential to facilitate persistence of the virus in the infected host. Thus, the EBV BHRF1 miRNAs may represent new therapeutic targets for the treatment of some EBV-associated lymphomas.
Zdroje
1. RickinsonAB
KieffE
2007 Epstein-Barr virus,
KnipeDM
HowleyPM
GriffinDE
LambRA
MartinMA
RoizmanB
StrausSE
Fields Virology Philadelphia Lippincott Williams & Wilkins 2655 2700
2. RickinsonAB
CallanMF
AnnelsNE
2000 T-cell memory: lessons from Epstein-Barr virus infection in man. Philos Trans R Soc Lond B Biol Sci 355 391 400
3. HammerschmidtW
SudgenB
1989 Genetic analysis of immortalizing functions of Epstein-Barr virus in human B-lymphocytes. Nature 340 393 397
4. CohenJI
WangF
MannickJ
KieffE
1989 Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci U S A 86 9558 9562
5. MannickJB
CohenJI
BirkenbachM
MarchiniA
KieffE
1991 The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J Virol 65 6826 6837
6. KayeKM
IzumiKM
KieffE
1993 Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A 90 9150 9154
7. HummeS
ReisbachG
FeederleR
DelecluseHJ
BoussetK
2003 The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc Natl Acad Sci U S A 100 10989 10994
8. LernerMR
AndrewsNC
MillerG
SteitzJA
1981 Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A 78 805 809
9. PfefferS
ZavolanM
GrasserFA
ChienM
RussoJJ
2004 Identification of virus-encoded microRNAs. Science 304 734 746
10. CaiX
SchaferA
LuS
BilelloJP
DesrosiersRC
2006 Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2 e23
11. CosmopoulosK
PegtelM
HawkinsJ
MoffettH
NovinaC
2009 Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 83 2357 2367
12. HutzingerR
FeederleR
MrazekJ
SchiefermeierN
BalwierzPJ
2009 Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome. PLoS Pathog 5 e1000547
13. BartelDP
2004 MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 281 297
14. KieffE
RickinsonAB
2007 Epstein-Barr virus and its replication.
KnipeDM
HowleyPM
GriffinDE
LambRA
MartinMA
RoizmanB
StrausSE
Fields Virology Philadelphia Lippincott Williams & Wilkins 2603 2654
15. XingL
KieffE
2007 Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication. J Virol 81 9967 9975
16. NeuhierlB
DelecluseHJ
2005 Molecular genetics of DNA viruses: recombinant virus technology. Methods Mol Biol 292 353 370
17. AubinJ
DaviF
Nguyen-SalomonF
LeboeufD
DebertC
1995 Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 9 471 479
18. KellyGL
LongHM
StylianouJ
ThomasWA
LeeseA
2009 An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link. PLoS Pathog 5 e1000341
19. PfefferS
SewerA
Lagos-QuintanaM
SheridanR
SanderC
2005 Identification of microRNAs of the herpesvirus family. Nat Methods 2 269 276
20. CullenBR
2009 Viral and cellular messenger RNA targets of viral microRNAs. Nature 457 421 425
21. BarthS
PfuhlT
MamianiA
EhsesC
RoemerK
2008 Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 36 666 675
22. UmbachJL
KramerMF
JurakI
KarnowskiHW
CoenDM
2008 MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454 780 783
23. MurphyE
VanicekJ
RobinsH
ShenkT
LevineAJ
2008 Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc Natl Acad Sci U S A 105 5453 5458
24. LeiX
BaiZ
YeF
XieJ
KimCG
2010 Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12 193 199
25. Stern-GinossarN
ElefantN
ZimmermannA
WolfDG
SalehN
2007 Host immune system gene targeting by a viral miRNA. Science 317 376 381
26. XiaT
O'HaraA
AraujoI
BarretoJ
CarvalhoE
2008 EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 68 1436 1442
27. HutchingsIA
TierneyRJ
KellyGL
StylianouJ
RickinsonAB
2006 Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines. J Virol 80 10700 10711
28. PrattZL
KuzembayevaM
SenguptaS
SugdenB
2009 The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 386 387 397
29. HafnerM
LandthalerM
BurgerL
KhorshidM
HausserJ
2010 Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141 129 141
30. GrahamFL
SmileyJ
RussellWC
NairnR
1977 Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36 59 74
31. ShawG
MorseS
AraratM
GrahamFL
2002 Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. Faseb J 16 869 871
32. PulvertaftRJV
1964 Cytology of Burkitt's lymphoma (African lymphoma). Lancet 1 238 240
33. TakadaK
HorinouchiK
OnoY
AyaT
OsatoT
1991 An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5 147 156
34. ClementsGB
KleinG
PoveyS
1975 Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. Int J Cancer 16 125 133
35. HayflickL
1965 The Limited in Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res 37 614 636
36. DelecluseHJ
HilsendegenT
PichD
ZeidlerR
HammerschmidtW
1998 Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95 8245 8250
37. GriffinBE
BjorckE
BjursellG
LindahlT
1981 Sequence complexity of circular Epstein-Bar virus DNA in transformed cells. J Virol 40 11 19
38. FeederleR
BannertH
LipsH
Muller-LantzschN
DelecluseHJ
2009 The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication. J Virol 83 4952 4962
39. ChenC
RidzonDA
BroomerAJ
ZhouZ
LeeDH
2005 Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33 e179
40. BellAI
GrovesK
KellyGL
Croom-CarterD
HuiE
2006 Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J Gen Virol 87 2885 2890
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 2
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Genetic Mapping Identifies Novel Highly Protective Antigens for an Apicomplexan Parasite
- Type I Interferon Signaling Regulates Ly6C Monocytes and Neutrophils during Acute Viral Pneumonia in Mice
- Infections in Cells: Transcriptomic Characterization of a Novel Host-Symbiont Interaction
- The ESCRT-0 Component HRS is Required for HIV-1 Vpu-Mediated BST-2/Tetherin Down-Regulation